Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mucosa-associated Lymphoid Tissue Lymphoma (MALT)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT01728207
What this trial is testing

Phase I Dose Escalation Study of IMMU-114 in Relapsed or Refractory NHL and CLL

Who this might be right for
Non-hodgkin's LymphomaFollicular LymphomaMantle Cell Lymphoma+3 more
Gilead Sciences 30
Testing effectiveness (Phase 2)Study completedNCT04205409
What this trial is testing

Nivolumab for Relapsed, Refractory, or Detectable Disease Post Chimeric Antigen Receptor T-cell Treatment in Patients With Hematologic Malignancies

Who this might be right for
Recurrent Chronic Lymphocytic LeukemiaRecurrent Diffuse Large B-Cell LymphomaRecurrent Follicular Lymphoma+15 more
University of Washington 20
Not applicableLooking for participantsNCT06712459
What this trial is testing

Integrated Molecular and Clinical Profiling of Transformed Splenic Marginal Zone Lymphoma

Who this might be right for
Transformed Splenic Marginal Zone Lymphoma
International Extranodal Lymphoma Study Group (IELSG) 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT04416451
What this trial is testing

A Phase II Study Using Rituximab Plus Venetoclax in the Front Line Treatment of Marginal Zone Lymphoma

Who this might be right for
Marginal Zone Lymphoma
Memorial Sloan Kettering Cancer Center 6
Early research (Phase 1)Study completedNCT00126646
What this trial is testing

BL22 Immunotoxin in Treating Patients With Refractory Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, or Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphoma
MedImmune LLC 24
Early research (Phase 1)Active Not RecruitingNCT03884998
What this trial is testing

Copanlisib and Nivolumab in Treating Patients With Richter's Transformation or Transformed Indolent Non-Hodgkin Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaDiffuse Large B-Cell LymphomaFollicular Lymphoma+4 more
City of Hope Medical Center 27
Early research (Phase 1)Study completedNCT02049541
What this trial is testing

Study of BKM120 & Rituximab in Patients With Relapsed or Refractory Indolent B-Cell Lymphoma

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Grade 1 Follicular Lymphoma+6 more
Kami Maddocks, MD 18
Testing effectiveness (Phase 2)Study completedNCT00004907
What this trial is testing

Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Northwestern University
Testing effectiveness (Phase 2)Study completedNCT01239394
What this trial is testing

Ofatumumab for Initial Systemic Treatment of Indolent B-cell Lymphoma

Who this might be right for
Follicular LymphomaMarginal Zone LymphomaSmall Lymphocytic Lymphoma
Massachusetts General Hospital 43
Testing effectiveness (Phase 2)Study completedNCT00105001
What this trial is testing

Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Myelodysplastic/Myeloproliferative Neoplasm, UnclassifiablePreviously Treated Myelodysplastic SyndromeRefractory Chronic Lymphocytic Leukemia+113 more
Fred Hutchinson Cancer Center 210
Testing effectiveness (Phase 2)Active Not RecruitingNCT04245839
What this trial is testing

Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma (NHL)

Who this might be right for
Lymphoma, Non-Hodgkin
Celgene 276
Testing effectiveness (Phase 2)Study completedNCT00031642
What this trial is testing

Monoclonal Antibody Therapy in Relapsed Non-Hodgkin's After Chemotherapy and Autologous Stem Cell Transplantation

Who this might be right for
Lymphoma
University of Nebraska 26
Testing effectiveness (Phase 2)Study completedNCT00003269
What this trial is testing

Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors

Who this might be right for
Breast CancerDrug/Agent Toxicity by Tissue/OrganLung Cancer+3 more
Scripps Health 20
Early research (Phase 1)Study completedNCT00003956
What this trial is testing

Combination Chemotherapy in Treating Patients With Advanced Cancer

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
Memorial Sloan Kettering Cancer Center 25
Not applicableStudy completedNCT00956475
What this trial is testing

Quality of Life in Younger Leukemia and Lymphoma Survivors

Who this might be right for
Anxiety DisorderCancer SurvivorFatigue+7 more
Case Comprehensive Cancer Center 48
Early research (Phase 1)Ended earlyNCT00096005
What this trial is testing

Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAIDS-related Peripheral/Systemic LymphomaAnaplastic Large Cell Lymphoma+54 more
National Cancer Institute (NCI) 36
Not applicableUnknownNCT04097067
What this trial is testing

ISRT 20 Gy for Indolent Localized Gastrointestinal (GI)-Lymphoma

Who this might be right for
Follicular Lymphoma (Gastric or Duodenal)Marginal Zone Lymphoma (Gastric or Duodenal)
University Hospital Muenster 83
Testing effectiveness (Phase 2)Ended earlyNCT01805037
What this trial is testing

Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+114 more
Northwestern University 20
Testing effectiveness (Phase 2)Study completedNCT00005601
What this trial is testing

Combination Chemotherapy Plus Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT05783596
What this trial is testing

Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma

Who this might be right for
Follicular LymphomaMarginal Zone LymphomaIndolent Non-hodgkin Lymphoma
Reid Merryman, MD 47
Next Page